<DOC>
	<DOCNO>NCT00848458</DOCNO>
	<brief_summary>The purpose prospective , randomize , control , single-blinded investigation study efficacy , tolerability safety azelaic acid iontophoresis ( AAI ) versus topical treatment azelaic acid cream female patient melasma .</brief_summary>
	<brief_title>Azelaic Acid Iontophoresis Versus Topical Azelaic Acid Cream Treatment Melasma</brief_title>
	<detailed_description>Patients randomize allocate conceal manner one two treatment arm : AAI topical azelaic acid cream . Azelaic acid iontophoresis treatment schedule : Patients randomize AAI group receive iontophoresis 15 % azelaic acid twice weekly period 12 week . Azelaic acid topical treatment schedule : Patients randomized topical treatment group receive topical treatment 20 % azelaic acid cream twice daily period 12 week . Besides emollient additional specific treatment allow study . The use broad spectrum ( UVA+UVB ) sunscreen recommend entire study period ( 9 month ) . Follow-up period : After completion active study period ( 3 month treatment group ) , maintenance efficacy treatment schedule follow quarterly 6 month</detailed_description>
	<mesh_term>Melanosis</mesh_term>
	<mesh_term>Azelaic acid</mesh_term>
	<criteria>Woman MASI Score 6 Age : 18 year Skin Type : III , IV , V Skin Type : I , II , VI Pregnant lactate woman Local therapy intenttotreat area within last 6 month Patient pacemaker metal implant Epileptic Mental incompetence understand protocol Known allergic reaction one use substance Serious encroachment physical condition</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2010</verification_date>
	<keyword>Azelaic Acid</keyword>
	<keyword>Iontophoresis</keyword>
</DOC>